Search for: "v. HOFFMAN et al" Results 101 - 120 of 170
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jul 2007, 10:40 am
" In Indiana Department of Financial Institutions, et al. v. [read post]
22 Oct 2007, 10:53 am
Creation of South-West Lake Maxinkuckee Conservancy District, et al., a 20-page opinion, Cheif Judge Baker writes:Appellant-intervenor John Crist appeals the trial court's order creating the South-West Lake Maxinkuckee Conservancy District (the Conservancy District). [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in… [read post]
9 Jan 2014, 1:37 pm
Page Keeton, et al., Prosser & Keeton on the Law of Torts §96, at 686 (5th ed. 1984). [read post]
25 Dec 2013, 7:00 am by Robert Kreisman
PaulMark Land Acquisition Illinois Appellate Court Agrees With Trial Court in Dismissing Breach of Fiduciary Duty Claim for Missing Facts; Caplice, et al. v. [read post]
7 Jun 2010, 8:05 am by Lyle Denniston
The dispute reached the Court in Pontiac School District, et al., v. [read post]
23 Apr 2009, 10:00 pm
(Spicy IP) India: Assessing India’s innovation climate (Biotech Blog) Kenya’s anti-counterfeit legislation, India protest (Afro-IP) Mexico: Pharmaceutical trade marks: the Health Law pitfall for applicants (International Law Office) US: BIO IP Counsels’ Committee: Q Todd Dickinson and E Anthony Figg on patent reform (Patent Docs) US: Amgen VP makes case for longer exclusivity period in follow-on biologics legislation (Patent Docs)   Products Cepham –… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
12 Oct 2011, 8:31 am by Lawrence B. Ebert
Moore et al., Moore’s Federal Practice ¶ 203.10[2][a], at 14 (3d ed. 2005)).In this case, the district court entered an order ex- pressly denying Bosch’s motion for entry of a permanent injunction. [read post]
20 May 2019, 8:00 am by Robert Kreisman
Symphony Countryside, LLC, Countryside Care Centre, Inc., Countryside Care, LLC, et al., 2019 IL App (1st) 180160 (March 19, 2019). [read post]